Join
Live feed
·
PRReleasevia Quantisnow
Apimeds Pharmaceuticals US Inc. logo

Apimeds Pharmaceuticals and Lōkahi Therapeutics Announce FDA Type C Meeting Scheduled for LT‑100 (Apitox)

ByQuantisnow·Wall Street's wire, on your screen.
APUS· Apimeds Pharmaceuticals US Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track APUS (Apimeds Pharmaceuticals US Inc.) and more on Quantisnow.